Adipokines and highly active antiretroviral therapy related lipodystrophy: Clinical study of 52 cases

National Medical Journal of China

Volumn 89, Issue 13, 2009, Pages 867-871

  Tao, Mei Mei ^a   Zhang, Lu ^b   Qiu, Zhi Feng ^b   Xie, Jing ^b   Han, Yang ^b   Yu, Wei ^b   Li, Ming ^b   Li, Tai Sheng ^b  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^b NONE

Author keywords

Acquired immunodeficiency syndrome; Antiretroviral therapy, highly active; Hyperlipidemia; Leptin

Indexed keywords

ADIPONECTIN; ANTIRETROVIRUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY REGIONS; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERINSULINEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; METABOLIC DISORDER; PREVALENCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADIPONECTIN; ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; INSULIN; INSULIN RESISTANCE; LEPTIN; LIPIDS; LIPODYSTROPHY; MALE; MIDDLE AGED;

EID: 77954892669     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.13.002     Document Type: Article

References (20)

1. Bernasconi E, Boubaker K, Junghans C, et al. Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr, 2002, 31:50-55.
2. Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS, 2001, 15:1389-1398. (Pubitemid 32662290)
3. Miller J, Carr A, Emery S, et al. HIV lipodystrophy: prevalence, severity and correlates of risk in Australia. HIV Med, 2003, 4:293-301. (Pubitemid 36949887)
4. d'Arminio A, Sabin CA, Phillips AN, et al. Cardio- and cerebrovascular events in HIV-infected persons. AIDS, 2004, 18:1811-1817.
5. Friis-Moller N, Sabin CA, Weber R, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med, 2003, 349:1993-2003.
6. Tsiodras S, Mantzoros C. Leptin and adiponectin in the HIV associated metabolic syndrome: physiologic and therapeutic implications. Am J Infect Dis, 2006, 2:141-152.
7. Addy CL, Cavrila A, Tsiodras S, et al. Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy. J Clin Endocrinol Metab, 2003, 88:627-636. (Pubitemid 36207802)
8. Nagy GS, Tsiodras S, Martin LD, et al. Human immunodeficiency virus type 1-related lipoatrophy and lipohypertrophy are associated with serum concentrations of leptin. Clin Infect Dis, 2003, 36:795-802. (Pubitemid 36337987)
9. Mynarcik DC, Combs T, Menurlan MA, et al. Adiponectin and leptin levels in HIV-infected subjects with insulin resistance and body fat redistribution. J Acquir Immune Defic Syndr, 2002, 31:514-520. (Pubitemid 35448659)
10. Sweeney LL, Brennan AM, Mantzoros CS. The role of adipokines in relation to HIV lipodystrophy. AIDS, 2007, 21:895-904.
11. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidemia and insulin resistance in patients receiving HIV pretease inhibitors. AIDS, 1998, 12:F51-58. (Pubitemid 28190689)
12. Viraben R, Aquilina C. Indinavir-associated lipodystrophy. AIDS, 1998, 12:F37-39.
13. Chene G, Angelini E, Cotte L, et al. Bole of long-term nucleoside-analogue therapy in lipodystrophy and metabolic disorders in human immunodeficiency virus-infected patients. Clin Infect Dis, 2002, 34:649-657. (Pubitemid 34165328)
14. Mallal SA, John M, Moore CB, et al. Contribution of nucleoside analogue reverse transcriptase inhibitors to aubeutaneous fat wasting in patients with HIV infection. AIDS, 2000, 14:1309-1316. (Pubitemid 30459502)
15. Heath KV, Hogg RS, Singer J, et al. Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based chort. J Acquir Immune Defic Syndr, 2002, 30:440-447. (Pubitemid 34857319)
16. Estrada V, Martínez-Larrad MT, González-Sánchez JL, et al. Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy. Metabolism, 2006, 55:940-945. (Pubitemid 43902897)
17. Carr A. HIV lipodystrophy: risk factors, pathogenesis, diagnosis and management. AIDS, 2003, 17 Suppl:S141-148. (Pubitemid 36667790)
18. Hadigan C, Meigs JB, Coreoran C, et al. Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin Infect Dis, 2001, 32:130-139. (Pubitemid 32150958)
19. Friis-Moller N, Weber R, Reiss P, et al. Cardiovascular disease risk factors in HIV patients-association with antiretroviral therapy. Results from the DAD study. ADIS, 2003, 17:1179-1193.